20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
DexCom Inc (DXCM) operates in the Health Care Equipment industry and is headquartered in San Diego, United States with about 11,000 employees. Its market capitalization is roughly $34 billion. In the fiscal year ended 2025-12-31, DXCM reported $4.7B in revenue and $836M in net income.
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally.
Interactive charts & full statements → Open the DXCM valuation workbench →
| Income statement | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $5.0B | $4.7B | $4.0B | $3.6B | $2.9B | $2.4B | $1.9B | $1.5B | $1.0B | $718M | $573M | $402M | $259M | $160M | $100M | $76M | $49M | $30M | $10M | $5M | $2M |
| Gross Profit | $3.1B | $2.8B | $2.4B | $2.3B | $1.9B | $1.7B | $1.3B | $932M | $664M | $492M | $378M | $278M | $176M | $100M | $47M | $36M | $18M | $4M | ($6M) | ($8M) | ($9M) |
| Gross Margin % | 62.5% | 60.1% | 60.5% | 63.2% | 64.7% | 68.6% | 66.4% | 63.1% | 64.4% | 68.5% | 66.0% | 69.2% | 68.0% | 62.6% | 46.7% | 47.0% | 37.9% | 12.3% | -56.2% | -175.2% | -405.1% |
| Operating Income (EBIT) | $1.1B | $912M | $600M | $598M | $391M | $266M | $300M | $142M | ($186M) | ($42M) | ($64M) | ($57M) | ($22M) | ($29M) | ($56M) | ($45M) | ($45M) | ($46M) | ($53M) | ($47M) | ($49M) |
| Operating Margin % | 22.9% | 19.6% | 14.9% | 16.5% | 13.4% | 10.9% | 15.5% | 9.6% | -18.1% | -5.9% | -11.2% | -14.2% | -8.3% | -18.1% | -55.8% | -58.8% | -93.1% | -154.4% | -537.0% | -1008.8% | -2273.0% |
| Net Income | $1.0B | $836M | $576M | $542M | $341M | $217M | $494M | $101M | ($127M) | ($50M) | ($66M) | ($58M) | ($22M) | ($30M) | ($54M) | ($45M) | ($55M) | ($54M) | ($55M) | ($46M) | ($47M) |
| Net Margin % | 20.1% | 17.9% | 14.3% | 14.9% | 11.7% | 8.9% | 25.6% | 6.9% | -12.3% | -7.0% | -11.4% | -14.3% | -8.6% | -18.6% | -54.5% | -58.7% | -113.5% | -180.3% | -560.9% | -991.5% | -2147.6% |
| EBITDA | $1.6B | $1.4B | $946M | $917M | $565M | $378M | $377M | $213M | ($75M) | ($20M) | ($49M) | ($46M) | ($13M) | ($22M) | ($49M) | ($41M) | ($51M) | ($43M) | ($50M) | ($43M) | ($47M) |
| Earnings Per Share (EPS) | $2.51 | $2.06 | $1.40 | $1.27 | $0.80 | $0.51 | $1.27 | $0.27 | $-0.36 | $-0.15 | $-0.20 | $-0.18 | $-0.07 | $-0.10 | $-0.20 | $-0.17 | $-0.24 | $-0.30 | $-0.47 | $-0.41 | $-0.43 |
| Shares Outstanding (M) | 392M | 406M | 413M | 426M | 428M | 429M | 390M | 369M | 353M | 345M | 334M | 319M | 301M | 284M | 275M | 262M | 228M | 177M | 118M | 113M | 109M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $1.3B | $1.2B | $1.3B | $1.2B | $1.2B | $1.0B | $1.1B | $994M |
| Gross Profit | $830M | $750M | $793M | $731M | $689M | $589M | $656M | $594M |
| Gross Margin % | 63.4% | 62.9% | 62.9% | 60.5% | 59.5% | 56.9% | 58.9% | 59.7% |
| Operating Income (EBIT) | $318M | $255M | $323M | $242M | $213M | $134M | $189M | $152M |
| Operating Margin % | 24.3% | 21.4% | 25.6% | 20.1% | 18.4% | 12.9% | 17.0% | 15.3% |
| Net Income | $249M | $200M | $267M | $284M | $180M | $105M | $152M | $135M |
| Net Margin % | 19.0% | 16.7% | 21.2% | 23.5% | 15.5% | 10.2% | 13.6% | 13.5% |
| EBITDA | $389M | $340M | $410M | $421M | $309M | $219M | $274M | $237M |
| Earnings Per Share (EPS) | $0.64 | $0.51 | $0.67 | $0.70 | $0.44 | $0.26 | $0.37 | $0.33 |
| Shares Outstanding (M) | 392M | 394M | 399M | 407M | 408M | 408M | 407M | 410M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | $1.7B | $1.4B | $990M | $748M | $670M | $442M | $476M | $314M | $123M | $92M | $56M | $49M | $24M | $2M | ($33M) | ($30M) | ($43M) | ($39M) | ($37M) | ($33M) | ($44M) |
| Capital Expenditures (CapEx) | $344M | $364M | $359M | $237M | $365M | $389M | $199M | $180M | $67M | $66M | $56M | $33M | $16M | $8M | $10M | $8M | $7M | $3M | $2M | $3M | $3M |
| Free Cash Flow (FCF) | $1.4B | $1.1B | $631M | $512M | $305M | $53M | $277M | $134M | $56M | $26M | $0M | $16M | $7M | ($6M) | ($43M) | ($38M) | ($50M) | ($42M) | ($40M) | ($37M) | ($47M) |
| FCF Margin % | 28.3% | 23.1% | 15.6% | 14.1% | 10.5% | 2.2% | 14.4% | 9.1% | 5.4% | 3.6% | 0.1% | 3.9% | 2.9% | -3.4% | -42.6% | -50.0% | -101.9% | -142.7% | -406.0% | -792.1% | -2170.1% |
| Dividends Paid | — | — | — | $1.2B | — | — | — | — | — | $0M | $0M | $0M | $0M | $0M | $0M | $0M | — | — | — | — | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | $269M | $526M | $294M | $660M | $303M | $184M | $301M | $200M |
| Capital Expenditures (CapEx) | $85M | $77M | $102M | $80M | $94M | $87M | $125M | $111M |
| Free Cash Flow (FCF) | $184M | $449M | $192M | $579M | $209M | $97M | $177M | $88M |
| FCF Margin % | 14.1% | 37.7% | 15.2% | 47.9% | 18.1% | 9.3% | 15.9% | 8.9% |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $6.5B | $6.3B | $6.5B | $6.3B | $5.4B | $4.9B | $4.3B | $2.4B | $1.9B | $904M | $403M | $292M | $185M | $122M | $106M | $120M | $77M | $47M | $44M | $77M | $65M |
| Cash & Cash Equivalents | $1.1B | $918M | $606M | $566M | $642M | $1.1B | $818M | $446M | $1.1B | $442M | $94M | $86M | $72M | $43M | $8M | $3M | $5M | $4M | $13M | $23M | $18M |
| Total Liabilities | $3.8B | $3.6B | $4.4B | $4.2B | $3.3B | $2.9B | $2.5B | $1.5B | $1.3B | $485M | $119M | $71M | $44M | $38M | $29M | $16M | $16M | $65M | $83M | $70M | $8M |
| Total Debt (Short + Long-Term) | $1.3B | $1.3B | $2.5B | $2.5B | $2.0B | $1.7B | $1.7B | $1.1B | $1.0B | $361M | $39M | $2M | $5M | $7M | $7M | $0M | $1M | $47M | $63M | $62M | $3M |
| Total Shareholders' Equity | $2.6B | $2.7B | $2.1B | $2.1B | $2.1B | $2.0B | $1.8B | $883M | $663M | $419M | $284M | $221M | $140M | $84M | $77M | $104M | $61M | ($18M) | ($19M) | $7M | $57M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive DXCM viewer.
This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी
About TickerBase · Data methodology & sources · Privacy · Terms